Sinopharm Group Co. Ltd. (1099.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Sinopharm Group Co. Ltd., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 7.62x |
| P/B Ratio | 0.65x |
| P/S Ratio | 0.09x |
| Profitability | |
| Gross Margin | 7.2% |
| Operating Margin | 2.8% |
| Net Margin | 1.2% |
| EBITDA Margin | 3.3% |
| Liquidity | |
| Current Ratio | 1.41x |
| Quick Ratio | 1.15x |
| Leverage | |
| Debt/Equity | 1.29x |
YoY = year-over-year change. Source: FMP..